Patient Information
Captopril Qualigen 25 mg Tablets
Read this entire leaflet carefully before you start taking this medicine, as it contains important information for you.
1. What is Captopril Qualigen and what it is used for
2. What you need to know before taking Captopril Qualigen
3. How to take Captopril Qualigen
4. Possible side effects
5. Storage of Captopril Qualigen
6. Contents of the pack and additional informationl
Captopril Qualigenis a medication that belongs to the group of substances known as angiotensin-converting enzyme (ACE) inhibitors.Captoprilproduces a relaxation of blood vessels and reduces blood pressure.
Captopril Qualigenis indicated for the treatment of:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Captopril Qualigen:
Excessive sweating and dehydration should be avoided, as they may lead to a sudden drop in blood pressure.
Other medications and Captopril Qualigen
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Inform your doctor or pharmacist if you are taking any of the following medications used to treat high blood pressure (hypertension):
Your doctor may monitor your renal function, blood pressure, and electrolyte levels in the blood (such as potassium) at regular intervals.
See also the information under the heading "Do not take Captopril Qualigen".
Inform your doctor that you are taking Captopril Qualigen if you are to undergo surgery or receive anesthetics.
As with other medications used to lower blood pressure, this medication may be less effective in black patients.
Consult your doctor, even if any of the circumstances mentioned above have occurred at any time.
Your doctor may need to modify your dose and/or take other precautions:
Certain medications may interact with Captopril Qualigen. In these cases, it may be necessary to change the dose or discontinue treatment with one of them.
It is essential to inform your doctor if you are taking any of the following medications:
Taking Captopril Qualigen with food
The tablets should be swallowed with water and may be taken with or without food. Inform your doctor if you take potassium supplements or consume a diet rich in potassium.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
Captopril Qualigen is not recommended for use in the first trimester of pregnancy and is contraindicated in the second and third trimesters of pregnancy.
If administered during the second and third trimesters of pregnancy, angiotensin-converting enzyme inhibitors (the group to which captopril belongs) may cause fetal damage and death.
If pregnancy is detected, the administration of this medication should be discontinued as soon as possible.
Captopril Qualigen should not be administered during breastfeeding.
Driving and operating machinery
During treatment for high blood pressure, your ability to drive and operate machinery may be reduced, especially at the beginning of treatment, when the dose is changed, or when alcohol is consumed. Do not drive or operate machinery if you observe that this medication causes any inability to perform these functions.
Captopril Qualigen contains lactose
This medication contains lactose. If your doctor has indicated that you have a certain sugar intolerance, consult with them before taking this medication.
Follow exactly the administration instructions for Captopril Qualigen as indicated by your doctor. In case of doubt, consult your doctor again.
Remember to take your medication.
Your doctor will indicate the duration of treatment with Captopril Qualigen. Do not discontinue treatment beforehand, as it may worsen your condition
The dosage must be individualized, so your doctor will establish the appropriate dose for you and make any necessary adjustments.
Adults
Hypertension
The recommended initial dose is 25-50 mg per day, administered in two daily doses. Your doctor may gradually increase the dose up to 100-150 mg per day. Your doctor may recommend the concurrent administration of other medications that lower blood pressure.
Chronic heart failure
The recommended initial dose is 6.25-12.5 mg two to three times a day. Your doctor may gradually increase the dose up to a maximum of 150 mg per day.
Myocardial infarction
The usual dose is a test dose of 6.25 mg. Your doctor may gradually increase the dose up to a maximum of 150 mg per day.
Type 1 diabetic nephropathy
The recommended initial dose is 75-100 mg per day, administered in several daily doses.
Use in children and adolescents
The recommended initial dose is 0.30 mg/kg of body weight. In children who require special precautions, the initial dose should be 0.15 mg/kg of body weight. The use of this medication in children and adolescents should be initiated under close medical supervision.
Geriatric patients
In elderly patients with renal function impairment and other organic alterations, lower doses than those recommended should be administered.
Patients with renal insufficiency
Lower doses than those recommended should be administered.
If you estimate that the action ofCaptopril Qualigenis too strong or too weak, inform your doctor or pharmacist.
If you take moreCaptopril Qualigenthan you should
If you have taken moreCaptopril Qualigenthan you should, consult your doctor or pharmacist immediately.
The most frequent symptoms in case of overdose include severe hypotension, shock, stupor, bradycardia (slowing of heart rate), electrolyte imbalances, and renal failure.
In case of overdose or accidental ingestion, consult the Toxicological Information Service. Phone 915 620 420.
If you forgot to takeCaptopril Qualigen
Take the dose as soon as you remember on the same day. Do not take a double dose to compensate for the missed doses.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
The classification of side effects is based on the following frequencies:
Very common(may affect up to 1 in 10 people)
Common(may affect fewer than 1 in 10 people)
Uncommon(may affect fewer than 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect fewer than 1 in 10,000 people)
Frequency not known(cannot be estimated from available data).
The following side effects have been observed:
Blood and lymphatic system disorders
Very rare:abnormal blood cell counts, lymph node disorders, autoimmune diseases.
Metabolism and nutrition disorders
Rare:anorexia (loss of appetite).
Very rare:changes in blood tests related to potassium and glucose levels.
Mental and behavioural disorders
Common:sleep disorders.
Very rare:confusion, depression.
Nervous system disorders
Common:alteration of taste, dizziness.
Rare:feeling of sleepiness, headache, and tingling sensation.
Very rare:syncope, fainting.
Eye disorders
Very rare:blurred vision.
Cardiac disorders
Uncommon:tachycardia, angina pectoris, palpitations.
Very rare:cardiac arrest, cardiogenic shock.
Vascular disorders
Uncommon:hypotension, Raynaud's syndrome (crisis of pallor followed by cyanosis and erythema, which occurs in the fingers of the hand), flushing, pallor.
Respiratory, thoracic and mediastinal disorders
Common:cough and difficulty breathing.
Very rare:respiratory disorders.
Gastrointestinal disorders
Common:nausea, vomiting, gastric irritation, abdominal pain, diarrhea, constipation, dry mouth.
Rare:oral lesions.
Very rare:inflammation of the tongue, gastric ulcer, pancreatitis.
Hepatobiliary disorders
Very rare:hepatic disorder and yellow skin discoloration, hepatitis (inflammation of the liver) including necrosis, elevated liver enzymes and bilirubin.
Skin and subcutaneous tissue disorders
Common:itching with or without skin rash, skin rash, hair loss.
Uncommon:swelling of the arms, legs, face, lips, tongueand/orthroat.
Very rare:appearance of blisters accompanied by itching, Stevens-Johnson syndrome, sensitivity to
light, skin redness, skin peeling.
Musculoskeletal and connective tissue disorders
Very rare:muscle pain, joint pain.
Renal and urinary disorders
Rare:renal function disorders including renal failure and alterations in urine elimination.
Reproductive and breast disorders
Very rare:impotence, abnormal breast development in men.
General disorders and administration site conditions
Uncommon:chest pain, fatigue, malaise.
Very rare:fever.
Investigations
Very rare:abnormal blood cell counts in blood tests.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Usewww.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Store in the original packaging and maintain the packaging perfectly closed to protect it from moisture.
Do not store at a temperature above 30°C.
Do not use Captopril Qualigen after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Deposit the packaging and unused medicines at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and unused medicines. By doing so, you will help protect the environment.
Captopril Qualigen Composition
Appearance of the product and contents of the packaging
Captopril Qualigenis presented in the form of tablets. Each package contains 60 or 500 tablets.
Only some package sizes may be commercially available.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona – Spain
Responsible manufacturer:
Neuraxpharm Pharmaceuticals, S.L.
Avda. Barcelona, 69
08970 Sant Joan Despí (Barcelona)
Spain
Last review date of this leaflet: September 2021
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.